With sequencing expertise at single-cell resolution, GENEWIZ offers transcriptome and immune repertoire (TCR/BCR) profiling for validating therapeutic targets during discovery and pre-clinical development.
Engineer libraries of constructs and screen to identify leads.
Our new Sanger-based solution is uniquely designed for sequencing adeno-associated virus (AAV) inverted terminal repeat (ITR) regions for screening and validation of leads while working with AAV vectors for gene therapy delivery.
GENEWIZ and Brooks Life Sciences provide the tools to support your project from discovery to FDA approval.
THE GENEWIZ DIFFERENCE
CONTACT GENEWIZ & bROOKS lIFE sCIENCES
GENEWIZ Ph.D. experts available to discuss your project: